Division C Characteristics of the modified organism
United Kingdom
- 1..
Information relating to the genetic modification:
- (a)
methods used for the modification;
- (b)
methods used to construct and introduce the insert(s) into the recipient or to delete a sequence;
- (c)
description of the insert and/or vector construction;
- (d)
purity of the insert from any unknown sequence and information on the degree to which the inserted sequence is limited to the DNA required to perform the intended function;
- (e)
methods and criteria used for selection;
- (f)
sequence, functional identity and location of the altered/inserted/deleted nucleic acid segment(s) in question with particular reference to any known harmful sequence.
- (a)
- 2..
Information on the final GMO:
- (a)
description of genetic trait(s) or phenotypic characteristics and in particular any new traits and characteristics which may be expressed or no longer expressed;
- (b)
structure and amount of any vector and/or donor nucleic acid remaining in the final construction of the modified organism;
- (c)
stability of the organism in terms of genetic traits;
- (d)
rate and level of expression of the new genetic material. Method and sensitivity of measurement;
- (e)
activity of the expressed protein(s);
- (f)
description of identification and detection techniques including techniques for the identification and detection of the inserted sequence and vector;
- (g)
sensitivity, reliability (in quantitative terms) and specificity of detection and identification techniques;
- (h)
history of previous releases or uses of the GMO;
- (i)
considerations for human health and animal health, as well as plant health:
- (i)
toxic or allergenic effects of the GMOs and/or their metabolic products;
- (ii)
comparison of the modified organism to the donor, recipient or (where appropriate) parental organism regarding pathogenicity;
- (iii)
capacity for colonisation;
- (iv)
if the organism is pathogenic to humans who are immunocompetent:
-
diseases caused and mechanism of pathogenicity including invasiveness and virulence,
-
communicability,
-
infective dose,
-
host range, possibility of alteration,
-
possibility of survival outside of human host,
-
presence of vectors or means of dissemination,
-
biological stability,
-
antibiotic resistance patterns,
-
allergenicity,
-
availability of appropriate therapies;
-
- (v)
other product hazards.
- (i)
- (a)